NEW YORK, June 28 - Denise Gilbert, the new CEO of bioinformatics company Entigen, hopes to extend the company's middleware for integrating data across the continuum of genomics to clinical disease management, she told GenomeWeb Thursday.

Entigen, formed in December 2000 from the merger of eBioinformatics and Empatheon, is looking to provide a combination of products and services to customers in non-profit research institutions, and pharmaceutical and biotechnology companies, she said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.